Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forest Labs Sees Large Call Selling
Seeking Alpha
Thursday, October 14, 2010 - 5:21pm
tags:
Forest Labs
Genzyme Says Campath MS Success Helps Justify Higher Sanofi Buyout Offer
Bloomberg
Thursday, October 14, 2010 - 5:19pm
tags:
Genzyme, Campath, MS, multiple sclerosis, M&A, Sanofi
Talecris gets FDA approval for Gamunex-C, a new version of its immune disorder treatment
Yahoo/AP
Thursday, October 14, 2010 - 5:17pm
tags:
Talecris, Gamunex-C, FDA
Is Myriad Genetics About to be Taken Over?
Minyanville
Thursday, October 14, 2010 - 5:16pm
tags:
M&A, Myriad Genetics, Pfizer, Abbott Laboratories, Cephalon, Merck, Inotek
Genzyme sees signs of remission in 5-year MS drug data
Fierce Biotech
Thursday, October 14, 2010 - 11:53am
tags:
MS, multiple sclerosis, Campath, Genzyme
Genzyme to vest stock options if acquired
Bizjournals.com
Thursday, October 14, 2010 - 11:51am
tags:
stock options, Genzyme, M&A, Sanofi
GSK to donate 1B tablets of intestinal-worms drug for children
Bizjournals.com
Thursday, October 14, 2010 - 11:49am
tags:
GSK, donations, albendazole
NICE to compare Tyverb, Herceptin in breast cancer
Fierce Pharma
Thursday, October 14, 2010 - 11:16am
tags:
breast cancer, Tyverb, Herceptin, NICE, GSK
Merck And Johnson & Johnson Arbitration Is Delayed
Pharmalot
Thursday, October 14, 2010 - 11:10am
tags:
JNJ, Merck, arbitration, Remicade, Simponi
Bristol-Myers Drug Gets 2nd Look In Study
Investors.com
Thursday, October 14, 2010 - 11:09am
tags:
Bristol-Myers Squibb, Plavix, Sanofi
Merck / Ariad Pharmaceuticals: Results of Synergistic Collaboration Coming Soon
Seeking Alpha
Thursday, October 14, 2010 - 11:06am
tags:
Merck, Ariad Pharmaceuticals, ridaforolimus
Show Me the Money, Celgene
Motley Fool
Thursday, October 14, 2010 - 11:04am
tags:
Celgene
FDA may limit anemia drug use for kidney disease
Yahoo/AP
Thursday, October 14, 2010 - 11:03am
tags:
anemia, kidney disease, FDA, Amgen, Procrit, Aranesp, Epogen
Roche Q3 sales dip as top drug Avastin falters
Reuters
Thursday, October 14, 2010 - 9:36am
tags:
Roche, earnings, Avastin
China Biologic: Value and Growth From a Small-Cap Chinese Biotech?
Seeking Alpha
Thursday, October 14, 2010 - 9:34am
tags:
China, China Biologic
Is Titan Pharmaceuticals Finally Lining Up With the Big Boys?
Seeking Alpha
Thursday, October 14, 2010 - 9:33am
tags:
Titan, Probuphine
Is Gilead Sciences a Sell?
Motley Fool
Thursday, October 14, 2010 - 9:32am
tags:
Gilead Sciences, Amgen, Celgene, Genzyme
Update: Perfect FDA Drug Approval Pickers
TheStreet.com
Thursday, October 14, 2010 - 9:29am
tags:
FDA, Hospira, Human Genome Sciences, Alexza, Jazz Pharmaceuticals, Alkermes, Arena Pharmaceuticals, Amylin, Vivus, Avanir, Forest Labs, Biodel
Myriad Genetics Rises as Analyst Cites Test, Suggests Possible Acquisition
Bloomberg
Thursday, October 14, 2010 - 9:27am
tags:
Myriad Genetics, M&A, Roche, AstraZeneca, Sanofi
FDA Should Charge Drug Company CEOS, Agency Counsel Says
Bloomberg
Wednesday, October 13, 2010 - 6:16pm
tags:
Pharma CEOs, FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.